COO

SELL

The Cooper Companies, Inc.

Healthcare · Rank #223 · Analyzed Oct 18, 2026

$57.94

Current Price

$31.84

Intrinsic Value

-45.0%

Upside/Downside

2.5/10

Score

2.5/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score2.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 45.0%

Fair Value Range

Low$11.78

Base (IV)$31.84

High$48.26

Entry Points

Conservative$8.24

Moderate$11.78

Aggressive$22.29

Quality & Moat Breakdown

Return on Equity6.8% → 0/1.0

Debt LevelD/E 34 → 0.5/1.0

Revenue QualityGrowth 9.4%, margin Δ-12.9% +recovery → 1.0/1.0

Moat Strength2.0/5 → 0/1.0

Profit Margins13.5% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.